Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × inavolisib × Gynecologic × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Gynecologic 1 Breast 1

Conditions

Endometrial Neoplasms 1

Interventions

Carboplatin 59 Paclitaxel 45 pembrolizumab 38 Cyclophosphamide 28 Cisplatin 22 Bevacizumab 21 Nivolumab 19 fludarabine 15 Topotecan 13 olaparib 12 liposomal doxorubicin 12 aldesleukin 12 Gemcitabine 11 Filgrastim 11 durvalumab 10 Interleukin-2 10 Peripheral Blood Stem Cell Transplantation 9 Docetaxel 9 Taxes 8 fludarabine phosphate 7 Specimen Handling 7 Ipilimumab 7 lenvatinib 6 epacadostat 6 Drug Therapy 6 Biopsy 6 toripalimab 5 spartalizumab 5 rucaparib 5 niraparib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04486352 2025-09-04

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡